Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Adding Nebulized Epinephrine in Asthma Exacerbation Management in Pediatric Age Group Compared to Standard of Care: Superiority Trial

NCT05667727 is registered in ClinicalTrials.gov with Oman Medical Speciality Board as lead sponsor.

NCT NCT05667727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05667727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Adding Nebulized Epinephrine in Asthma Exacerbation Management in Pediatric Age Group Compared to Standard of Care: Superiority Trial
Lead sponsor
Oman Medical Speciality Board
Phase
Phase 4
Overall status
Completed
Start date
October 15, 2023
Completion date
June 1, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children, epinephrine causing adverse effects in therapeutic use, salbutamol adverse reaction, shortness of breath